223 related articles for article (PubMed ID: 2908747)
1. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA
Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
Guerreiro AS; Neves BC; Quina MG
Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
5. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
Asaka M; Kato M; Sato Y; Miyazaki T
Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of peptic ulcer disease.
Andersen BN
Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
9. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy of peptic ulcer disease.
McQuaid KR; Isenberg JI
Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
[TBL] [Abstract][Full Text] [Related]
11. Refractory peptic ulcers.
Arakawa T; Kobayashi K; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
[TBL] [Abstract][Full Text] [Related]
12. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
13. Drugs for treatment of peptic ulcers.
Dajani EZ; Trotman BW
J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
Wilde MI; McTavish D
Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
16. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists.
Helander HF; Simonsson M; Sundler F; Rutgersson K; Helander KG; Eriksson S
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):305-9. PubMed ID: 1978433
[TBL] [Abstract][Full Text] [Related]
17. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
Langtry HD; Wilde MI
Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole in the management of refractory duodenal ulcer.
Bardhan KD
Scand J Gastroenterol Suppl; 1989; 166():63-73. PubMed ID: 2574910
[TBL] [Abstract][Full Text] [Related]
20. Emerging strategies for managing peptic ulcer disease.
Freston JW
Scand J Gastroenterol Suppl; 1994; 201():49-54. PubMed ID: 8047824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
